Am J Transplant, Volume 21, Suppl 3 Archives - Page 139 of 139 - ATC Abstracts

2021 American Transplant Congress
BKV-Associated Urothelial Carcinoma in Patients After Renal and Extrarenal Carcinoma
A. Schwarz¹, J. Schmitz², J. Gottlieb³, C. Bara⁴, H. Haller¹, J. Braesen²
¹Nephrology Department, Hannover Medical School, Hannover, Germany, ²Institute of Pathology, Hannover Medical School, Hannover, Germany, ³Department of Pneumology, Hannover Medical School, Hannover, Germany, ⁴Department of Thoracic Surgery, Hannover Medical School, Hannover, Germany
*Purpose: Polyomavirus BK (BKV) reactivation or transmission is a wellknown problem in renal transplant (TX) patients with BKV nephropathy and interstitial cystitis. The role of…
2021 American Transplant Congress
The Incremental Cost of Transplanting Patients with 100% cPRA Under the Kidney Allocation System: A Single Center Analysis
R. Gumber, E. Kraus, K. Jackson, N. Alachkar
Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: Our group has described excellent three year patient and graft survival in patients with 100% cPRA undergoing kidney transplantation under the Kidney Allocation System…
2021 American Transplant Congress
The Extremes of KDPI: Even KDPI 95%+ Kidneys Can Be Used Successfully
A. Gilbert, J. Verbesey, B. Thomas, J. Moore, M. Cooper
Medstar Georgetown Transplant Institute, Washington, DC
*Purpose: While the use of kidneys with KDPIs greater than 85% has become common, there is still reluctance among centers to use the very highest…
2021 American Transplant Congress
Donation After Circulatory Death Kidney Transplantation Has Equal Long-Term Graft and Patient Survival as Donation After Brain Death: A Systematic Review and Meta-Analysis
E. Rijkse¹, S. Ceuppens¹, H. Qi², J. N. IJzermans¹, D. A. Hesselink³, R. C. Minnee¹
¹HPB/Transplant surgery, Erasmus Medical Center, Rotterdam, Netherlands, ²Biostatistics, Erasmus Medical Center, Rotterdam, Netherlands, ³Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, Netherlands
*Purpose: Donation after circulatory death (DCD) kidneys are not worldwide accepted yet due to concerns about inferior quality. To investigate whether these concerns are justified,…
2021 American Transplant Congress
True Living Donation Experiences: A Thematic Analysis of Storytelling from Kidney Living Donors
E. Ho¹, E. H. Wood², R. Pines³, L. A. Davis⁴, S. M. Advani⁵, A. D. Waterman²
¹Terasaki Institute, Los Angeles, CA, ²UCLA David Geffen School of Medicine, Los Angeles, CA, ³Cottage Hospital, Santa Barbara, CA, ⁴DeSales University, Center Valley, PA, ⁵National Human Genome Research Institute (NIH), Bethesda, MD
*Purpose: Personal experiences of living donors (LDs) or recipients (Rs) can motivate more individuals to pursue living donor kidney transplant. After building a library of…
2021 American Transplant Congress
Impact of Treatment of Subclinical Rejection at 2 Weeks After Kidney Transplantation, Compared by 1 Year Histologic Outcomes
O. Lee¹, K. Lee¹, J. Park¹, J. Lee², G. Kwon³, K. Kim⁴
¹Surgery, Samsung Medical Center, Seoul, Korea, Republic of, ²Medicine, Samsung Medical Center, Seoul, Korea, Republic of, ³Pathology, Samsung Medical Center, Seoul, Korea, Republic of, ⁴Biostatistics, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Subclinical rejection (SCR) is associated with chronic allograft nephropathy, which is the most common cause of allograft failure in kidney transplantation (KT). Therefore, early…
2021 American Transplant Congress
Renal Transplant is Safe in Septuagenarians
P. Serrano Rodriguez, J. Vonderau, K. Szempruch, C. S. Desai
Abdominal Transplant Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC
*Purpose: With increasing life expectancy, there has been increase in transplant rates amongst elderly recipients who often have more comorbidities than younger recipient. The aim…
2021 American Transplant Congress
The Impact of Fixed-Dose Alemtuzumab in Renal Transplant Recipients According to Weight
S. Mandala¹, N. Khodieva², A. Bigness¹, S. Mohamed², H. Mohammed¹, K. Robichaux², A. Brueckner³, R. Baliga⁴, J. Buggs⁵, A. Kumar¹, L. Bowman³
¹Morsani College of Medicine, University of South Florida, Tampa, FL, ²Honors College, University of South Florida, Tampa, FL, ³Transplant Pharmacy, Tampa General Hospital, Tampa, FL, ⁴Nephrology, Florida Kidney Physicians, Tampa, FL, ⁵Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: Alemtuzumab, a potent anti-CD52 monoclonal antibody is used for induction immunosuppression post-renal transplantation as a fixed 30mg dose regardless of the patient’s weight. The…
2021 American Transplant Congress
Belatacept Utilization During the Covid-19 Pandemic in the United States
M. MacConmara, A. Shubin, D. Wojciechowski, L. de Gregorio, J. Shah, P. Vagefi, C. S. Hwang
Department of Surgery, Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, TX
*Purpose: With the onset of the COVID-19 pandemic, many people in the United States were urged to stay at home. Kidney transplantation continued during this…